A latent herpes simplex virus infection was established in rabbit kidney cells. Treatment of the cells with 5-bromo-2-deoxyuridine after the latent infection was established had no effect on the rate of virus recovery but did extend the latent period before active virus growth resumed. In contrast to this, treatment of cells with 5-bromo-2-deoxyuridine or 5-iodo-2-deoxyuridine prior to infection with virus increased the subsequent rate of virus recovery.
A latent herpes simplex virus infection was established in rabbit kidney cells. Treatment of the cells with 5-bromo-2-deoxyuridine after the latent infection was established had no effect on the rate of virus recovery but did extend the latent period before active virus growth resumed. In contrast to this, treatment of cells with 5-bromo-2-deoxyuridine or 5-iodo-2-deoxyuridine prior to infection with virus increased the subsequent rate of virus recovery.
A number of studies have shown that 5-bromo-2-deoxyuridine (BUdR) and 5-iodo-2-deoxyuridine (IUdR) effectively inhibit the replication of herpes-virus in cell culture (9, 10, 14, 25) . Both drugs apparently inhibit virus growth after being incorporated into the virus nucleic acid (15) . Recent studies have indicated that these two thymidine analogues can stimulate active virus growth in cells that harbor virus in a latent state. Among the viruses reported to be activated by these chemicals are members of the oncornavirus group (1, 2, 12, 13, 16, 19, 20, 24) , papovaviruses (3, 4) , and the Epstein-Barr virus of the herpesvirus group (5) (6) (7) (8) (21) (22) (23) . In addition, pretreatment of cells with IUdR has been shown to enhance the replication of cytomegalovirus, another member of the herpesvirus group (17, 18) . Since Effects of BUdR on the recovery of HSV from cells infected with latent virus. To test the effects of BUdR on latent virus, virusinfected cultures were incubated at 41 C for 2 to 6 days and then transferred to 37 C and treated with 100 ,g of BUdR per ml. Untreated control cultures were handled in the same way. The BUdR-containing medium was replaced with inhibitor-free medium 4 days later. Cultures at 37 C were monitored daily for the appearance of CPE (Table 2) . Virus was eventually recovered from 25 to 32 control cultures for a reactivation rate of 78% and from 17 to 32 BUdR-treated cultures for a reactivation rate of 53%. Statistically this difference was not significant. However, the average lag period of the treated cultures was over twice as long as the average lag period of the control cultures. This difference was highly significant (P < 0.01).
In another experiment, virus-infected cultures were incubated at 41 C for 2 to 6 days and then transferred to 37 C. The cultures were incubated at 37 C for 3 days. After 3 days one-half of the cultures that did not show CPE was treated with 100 MAg of BUdR per ml, and the other half was kept as controls. The BUdRcontaining medium was replaced with inhibitor-free medium 4 days after the start of treatment, and the cultures were monitored daily for CPE (Table 3) . By waiting 3 days before beginning the BUdR treatment, all cultures which showed CPE within the first 3 days after transfer to 37 C were excluded from the data. By 5 x 103 plaque-forming units of virus and incubated at 41 C for 2 to 6 days. After incubation at 41 C, cultures were transferred to 37 C and incubated for 3 days. All cultures that showed CPE at the end of 3 days were discarded. One-half of the remaining cultures was treated with 100 Ag of BUdR per ml. The BUdR-containing medium was replaced with inhibitor-free medium 4 days later. Cultures at 37 C were monitored daily for CPE, and the recovery rates and average lag periods were determined. discarding these cultures, the average lag periods of both the treated and control groups were increased. The relationship between the two groups remained the same, however, as in the previous experiment. The average lag period of the BUdR-treated cultures was again over twice as long as the average lag period of the control cultures. This difference was highly significant (P < 0.01). In this experiment there was virtually no difference in the overall reactivation rates of the treated and control groups.
Since the difference between the average lag periods of the treated and control groups was highly significant in both experiments, no attempt was made to duplicate these results using IUdR.
Effects of pretreatment of celis with BUdR and IUdR on the subsequent recovery of virus. The ability of BUdR to affect the establishment of the latent infection was studied next. Cultures were treated with 100 Mg of BUdR per ml at the time of infection with virus and incubated at 41 C along with untreated control cultures. After incubation at 41 C for 2 to 6 days, the cultures were transferred to 37 C.
The inhibitor-containing medium was replaced with inhibitor-free medium at this time. The cultures were then incubated at 37 C and monitored for virus growth (Table 4) . Treatment of cultures with BUdR at the time of infection with virus resulted in a significantly higher reactivation rate after subsequent transfer to 37 C (P < 0.05). Furthermore, the average lag period of the treated group was reduced from the control value.
In another experiment IUdR was substituted /Ag/ml) I l I_I a Cultures were treated with 100 jig of BUdR per ml, infected with 5 x 103 plaque-forming units of virus, and incubated at 41 C for 2 to 6 days. After incubation at 41 C, cultures were transferred to 37 C, and the BUdR-containing medium was replaced with inhibitor-free medium. Cultures at 37 C were monitored daily for CPE, and the recovery rates and average lag periods were determined.
IUdR per ml, infected with virus, and incubated at 41 C along with untreated control cultures. After incubation at 41 C, the cultures were transferred to 37 C. The IUdR-containing medium was replaced with inhibitor-free medium, and the cultures were monitored for CPE ( Table  5) . The results observed with the IUdR treatment were the same as with the BUdR treatment. The IUdR-treated group had a significantly higher reactivation rate (P < 0.01), and the average lag period of the treated cultures was reduced from the control value.
DISCUSSION
Treatment of latent virus-infected rabbit kidney cells with BUdR failed to significantly affect the reactivation rate of virus from the infected cells. The failure to increase the reactivation rate is interesting because of the reported ability of this drug to stimulate other latent viruses. On the other hand, the failure to decrease the reactivation rate indicates that the latent virus is resistant to the normal antiviral effects of this drug. This substantiates our belief that the latent virus is not replicating in this model infection rather than replicating at a very slow rate.
The mechanism by which BUdR increased the average lag period of the treated cultures is not known. It is possible that virus reactivations were prevented. However, since BUdR was shown to be a potent inhibitor of active virus growth in control studies, it is possible that the temporary block that occurred after BUdR treatment was due not to inhibition of virus reactivations but to the inhibition of active virus growth after reactivations occurred.
Pretreatment of cells with BUdR or IUdR did a Cultures were treated with 25 ug of IUdR per ml, infected with 5 x 101 plaque-forming units of virus, and incubated at 41 C for 2 to 6 days. After incubation at 41 C, cultures were transferred to 37 C, and the IUdR-containing medium was replaced with inhibitor-free medium. Cultures at 37 C were monitored daily for CPE, and the recovery rates and average lag periods were determined. increase the reactivation rates and reduce the average lag periods of the treated groups. The reason for the increased reactivation rates and reduced lag periods is not fully understood. St. Jeor and Rapp (17, 18) found that pretreatment of cells with IUdR made the cells more susceptible to infection with cytomegalovirus. They postulated that some normal antiviral mechanism of the cells may have been inhibited. It is possible that the cells treated with BUdR or IUdR in these experiments were not able to eliminate the nongrowing virus at 41 C and therefore contained a greater number of latent viruses per culture after transfer to 37 C.
